Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940264149> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2940264149 abstract "Backgrounds: Deiodinase type 2 (DIO2) is a selenoenzyme involved in the synthesis of thyroid hormones. Chemerin is a newly investigated adipokine known also as novel chemokine. Both molecules have been recently expected and found to play an important role in inflammation and immunity. DIO2, for example, is upregulated during acute and chronic inflammation. In addition, inflammation-induced expression of DIO2 in macrophages has been confirmed, while chemerin modulates the activation and chemotaxis of immune cells. It is widely known that chronic obstructive pulmonary disease (COPD) – the most common lung disease in the world – is accompanied by an inflammatory process and immune activation. There are no studies demonstrating an association between DIO2, chemerin and COPD. The aim of this study was to estimate DIO2 and chemerin concentration in serum collected from patients suffering from COPD and to compare it with healthy subjects, as well as to correlate with basic and clinical characteristics. Methods: The study group included 50 patients with COPD and 30 healthy subjects. DIO2 and chemerin serum levels as well as c-reactive protein levels were determined in all the subjects using commercial enzyme-linked immunosorbent assay kits. The association between serum DIO2 and chemerin with sociodemographic and clinical variables was assessed. Results: DIO2 serum levels were significantly higher in the patients with COPD as compared to the control group (50.3±23.2 U/L vs. 13.3±13.1; p<0.00001). No differences were observed in serum chemerin levels between the patients and controls (107.559±86.695.6 vs. 100.701±53.805; p=0.54). Furthermore, there was no association between DIO2 and chemerin levels and other variables, and no correlation between both molecules. Conclusions: This study demonstrated that DIO2 levels were higher in the patients with COPD than in the control subjects. The examined molecules should be further investigated if they are intended to be considered markers of processes involved in COPD mechanisms." @default.
- W2940264149 created "2019-04-25" @default.
- W2940264149 creator A5002120627 @default.
- W2940264149 creator A5042010237 @default.
- W2940264149 creator A5044348723 @default.
- W2940264149 date "2019-04-12" @default.
- W2940264149 modified "2023-09-26" @default.
- W2940264149 title "Association of serum deiodinase type 2 level with chronic obstructive pulmonary disease in the Polish population" @default.
- W2940264149 doi "https://doi.org/10.18388/abp.2018_2761" @default.
- W2940264149 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30978267" @default.
- W2940264149 hasPublicationYear "2019" @default.
- W2940264149 type Work @default.
- W2940264149 sameAs 2940264149 @default.
- W2940264149 citedByCount "0" @default.
- W2940264149 crossrefType "journal-article" @default.
- W2940264149 hasAuthorship W2940264149A5002120627 @default.
- W2940264149 hasAuthorship W2940264149A5042010237 @default.
- W2940264149 hasAuthorship W2940264149A5044348723 @default.
- W2940264149 hasBestOaLocation W29402641491 @default.
- W2940264149 hasConcept C126322002 @default.
- W2940264149 hasConcept C134018914 @default.
- W2940264149 hasConcept C171269688 @default.
- W2940264149 hasConcept C194832188 @default.
- W2940264149 hasConcept C199901988 @default.
- W2940264149 hasConcept C203014093 @default.
- W2940264149 hasConcept C2776780178 @default.
- W2940264149 hasConcept C2778288131 @default.
- W2940264149 hasConcept C2778417266 @default.
- W2940264149 hasConcept C2780613262 @default.
- W2940264149 hasConcept C511355011 @default.
- W2940264149 hasConcept C526584372 @default.
- W2940264149 hasConcept C71924100 @default.
- W2940264149 hasConceptScore W2940264149C126322002 @default.
- W2940264149 hasConceptScore W2940264149C134018914 @default.
- W2940264149 hasConceptScore W2940264149C171269688 @default.
- W2940264149 hasConceptScore W2940264149C194832188 @default.
- W2940264149 hasConceptScore W2940264149C199901988 @default.
- W2940264149 hasConceptScore W2940264149C203014093 @default.
- W2940264149 hasConceptScore W2940264149C2776780178 @default.
- W2940264149 hasConceptScore W2940264149C2778288131 @default.
- W2940264149 hasConceptScore W2940264149C2778417266 @default.
- W2940264149 hasConceptScore W2940264149C2780613262 @default.
- W2940264149 hasConceptScore W2940264149C511355011 @default.
- W2940264149 hasConceptScore W2940264149C526584372 @default.
- W2940264149 hasConceptScore W2940264149C71924100 @default.
- W2940264149 hasLocation W29402641491 @default.
- W2940264149 hasOpenAccess W2940264149 @default.
- W2940264149 hasPrimaryLocation W29402641491 @default.
- W2940264149 hasRelatedWork W2005744729 @default.
- W2940264149 hasRelatedWork W2070335885 @default.
- W2940264149 hasRelatedWork W2079710179 @default.
- W2940264149 hasRelatedWork W2114237571 @default.
- W2940264149 hasRelatedWork W2122184385 @default.
- W2940264149 hasRelatedWork W2163236351 @default.
- W2940264149 hasRelatedWork W2172055973 @default.
- W2940264149 hasRelatedWork W2547625788 @default.
- W2940264149 hasRelatedWork W2768044612 @default.
- W2940264149 hasRelatedWork W3181036828 @default.
- W2940264149 isParatext "false" @default.
- W2940264149 isRetracted "false" @default.
- W2940264149 magId "2940264149" @default.
- W2940264149 workType "article" @default.